(HALO) Halozyme Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Halozyme Therapeutics | (HALO) share price targets
Complete technical analysis of Halozyme Therapeutics (HALO) by charts plus indicators, forecast predictions and share price targets for Halozyme Therapeutics (HALO)
Halozyme Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-07 View latest technical analysis
10 day averaged volume of Halozyme Therapeutics is 1385990
| Date | Daily Closing Price | Open | High | Low | Volume |
| 07 Mon Oct 2024 | 53.85 | 57.92 | 57.98 | 53.32 | 1.771 times |
| 04 Fri Oct 2024 | 59.18 | 60.56 | 61.56 | 58.51 | 0.787 times |
| 03 Thu Oct 2024 | 60.43 | 58.12 | 62.00 | 57.63 | 1.34 times |
| 02 Wed Oct 2024 | 58.16 | 56.55 | 58.39 | 56.20 | 0.966 times |
| 01 Tue Oct 2024 | 56.64 | 56.97 | 57.19 | 55.89 | 0.954 times |
| 30 Mon Sep 2024 | 57.24 | 56.87 | 57.59 | 56.53 | 0.693 times |
| 27 Fri Sep 2024 | 56.97 | 57.35 | 58.04 | 56.84 | 0.87 times |
| 26 Thu Sep 2024 | 56.95 | 55.91 | 57.04 | 55.80 | 1.151 times |
| 25 Wed Sep 2024 | 55.87 | 56.50 | 56.67 | 55.43 | 0.932 times |
| 24 Tue Sep 2024 | 56.20 | 58.60 | 58.60 | 55.95 | 1.595 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 53.7, for a target of 56.5 or 58.87
Share price targets for Halozyme Therapeutics (HALO)
| Target Type | Value |
| Downside Target | 43.63 |
| Downside Target | 50.68 |
| Downside Target | 53.00 |
| Upside Target | 55.43 |
| Upside Target | 57.09 |
| Upside Target | 59.62 |
| Upside Target | 62.00 |
| Upside Target | 62.93 |
| Upside Target | 63.50 |
| Upside Target | 64.18 |
| Upside Target | 65.53 |
Intraday share price targets for Halozyme Therapeutics (HALO)
| Target Type | Value |
| Downside Intraday Target | 52.12 |
| Downside Intraday Target | 50.39 |
| Upside Intraday Target | 56.78 |
| Upside Intraday Target | 59.71 |
| Upside Intraday Target | 55.05 |
Weekly technical analysis of Halozyme Therapeutics (HALO)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 07 Mon Oct 2024 | 53.85 | 57.92 | 57.98 | 53.32 | 0.374 times |
| 04 Fri Oct 2024 | 59.18 | 56.87 | 62.00 | 55.89 | 0.901 times |
| 27 Fri Sep 2024 | 56.97 | 59.62 | 59.62 | 55.43 | 0.884 times |
| 20 Fri Sep 2024 | 59.24 | 62.78 | 63.50 | 58.71 | 1.689 times |
| 13 Fri Sep 2024 | 62.30 | 59.95 | 62.93 | 58.59 | 0.952 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Halozyme Therapeutics (HALO)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 07 Mon Oct 2024 | 53.85 | 56.97 | 62.00 | 53.32 | 0.304 times |
| 30 Mon Sep 2024 | 57.24 | 63.59 | 64.18 | 55.43 | 0.887 times |
| 30 Fri Aug 2024 | 63.85 | 55.52 | 65.53 | 51.46 | 1.083 times |
| 31 Wed Jul 2024 | 55.26 | 52.23 | 57.09 | 50.68 | 0.872 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Halozyme Therapeutics (HALO)
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term and the sell signal is strong.
Halozyme Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Halozyme Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 56.93 and Halozyme Therapeutics (HALO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term and the sell signal is strong.
Halozyme Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Halozyme Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 56.93 and Halozyme Therapeutics (HALO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.